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Abstract
Objective. Retinal injury induced by ethanol consumption has 
been previously reported in animal models, including biochemical, 
histological and functional alterations. These results need to be 
clinically tested in alcoholic patients which do not report several 
systemic or ophthalmic diseases. Methods. Six patients with alcohol 
use disorder were recruited from an ‘Alcoholism Treatment Unit’. 
All of them with active alcohol consumption when the study was 
conducted or that had stopped drinking six months prior to the 
study, with no ocular disease or visual acuity alterations. All patients 
underwent fundus photography, optical coherence tomography (OCT) 
as well as visual field test. Electrophysiological tests were conducted 
to check retinal function: Ganzfeld Electroretinogram (ERG), Pattern 
Electroretinogram (PERG), Multifocal Electroretinogram (mfERG), 
and also Visual Evoked Potential (VEP). Results.Visual acuity was 
normal in all cases as well as fundus photography and visual field 
test. The OCT showed a mild decrease in the retinal nerve fiber layer 
thickness average in three patients. Five patients showed impairments 
in mfERG response, decreased amplitude in ERG response and no 
significant alterations in PERG and VEP. Conclusion. Although 
standard ophthalmic tests did not show signs of an ocular disease, the 
study of electrical function showed different impairments in almost all 
patients. The alterations reported in mfERG and ERG recordings could 
reflect inner retina injury, thus supporting the possible existence of an 
alcoholic retinopathy. Further studies with larger number of subjects 
are necessary to assess the specific impact of other factors such as 
tobacco or nutritional status on patients with alcohol use disorder.
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1. Introduction
Alcohol is a psychoactive substance with dependence-
producing properties. As described in The World Health 
Organization (WHO) “Global Status Report on Alcohol 
and Health 2014”, consumption of and problems related 
to alcohol vary widely around the world, but the burden of 
disease and death remains significant in most countries. 
The harmful use of alcohol ranks among the top five 
risk factors for disease, disability and death throughout 
the world; it is a causal factor in more than 200 disease 
and injury conditions (and has also serious social and 
economic consequences for individuals other than the 
drinker, and for society at large).
Ethyl alcohol (ethanol) consumption has a high 
prevalence in our study population, at least 84.4% for 
men and 72.7% for women between 15 and 64 years 
old consumed alcohol in the last month [1]; chronic 
consumption is also important, between 4.7 and 13% of 
the population in different studies [2,3], although this is 
not normally recognized in the surveys.
Alcohol-related peripheral neuropathy (ALN) is a 
potentially debilitating complication of alcoholism that 
results in sensory, motor, and autonomic dysfunction [4], 
which initially was widely assumed to primarily reflect 
consequences of nutritional deficiency [5]. In recent 
studies, failure of thiamine treatment to reverse ALN, 
together with new information demonstrating clinical 
and electrophysiological distinctions between ALN 
and nutritional deficiency neuropathies, suggests that 
alcohol itself may significantly predispose and enhance 
development of neuropathy in the appropriate clinical 
setting [6,7,8,9]. Thus, ethanol exerts its deleterious 
effects metabolically via oxidative and nonoxidative 
Journal of Drug and Alcohol Research2
pathways [10], involving free radical production and lipid 
peroxidation [11], potentially leading to an imbalance 
between oxidants and antioxidants in favor of the former, 
resulting in an increased oxidative stress [12].
In the visual system, it is known that long-term ethanol 
consumption causes clinical manifestations that were 
also attributed to nutritional deficits rather than a direct 
effect of ethanol [13,14]. Increasing evidence suggest that 
oxidative stress contributes to the pathogenesis of many 
ocular neurodegenerative disorders, such as diabetic 
retinopathy [15], age-related macular degeneration [16] 
or uveitis [17,18,19,20]. Also our research group has 
previously reported that chronic alcohol consumption 
induces oxidative stress in rat optic nerves [7], which 
seems to mediate direct ethanol toxicity related to 
oxidative stress, discarding the influence of the nutritional 
status on the parameters studied.
The retina, which is the neurosensorial ocular tissue, is 
extremely rich in membranes with polyunsaturated lipids 
[21], making it particularly sensitive to oxygen free 
radicals and lipid peroxidation [22]. Although alcoholic 
retinopathy has not yet been described as a disease and 
no defining diagnostic criteria exist at the moment, our 
research group has previously reported ethanol-induced 
biochemical, histological and functional alterations in 
rats [8,23]. These results need to be clinically tested in 
alcoholic patients without ophthalmic disease, being this 
issue the main objective of our study.
2. Methods
Data were available for six alcoholic patients, all of them 
active users of alcohol when the study was conducted 
or that had stopped drinking six months prior to the 
study. Subjects were free of ocular disease or any visual 
acuity alterations. There was no severe systemic disease, 
mainly hypertension, diabetes mellitus or liver disease. 
Diagnosis was established clinically by a retina specialist 
and confirmed by visual acuity (measured following 
the guidelines from Early Treatment Retinopathy Study 
(EDTRS), 1985) [24], fundus photography, optical 
coherence tomography (OCT) and visual field test.
Fundus photography was obtained with a TRC-50IX-
Retinal Camera from TOPCON®, with a MY-10 camera 
and IMAGEnet 2000 v.2.59 imaging software also from 
TOPCON®.
OCT was recorded with a 3D-OCT-2000 equipment from 
TOPCON®. The evaluation of the optic nerve consisted 
of the measurement of average retinal nerve fiber layer 
(RNFL) thickness, as well as an interpretation of the 
spatial distribution in quadrants and clock-hours.
Visual field data were acquired in both eyes by 
campimetry using a Humphrey FA II Visual Field 
Analyzer (Carl Zeiss, Inc. San Leandro, CA USA).
Once ocular disease was discarded, electrophysiological 
tests were conducted to test retinal function. Thus, all 
patients also underwent a Ganzfeld Electroretinogram 
(ERG), Pattern Electroretinogram (PERG), a Multifocal 
Electroretinogram (mfERG) and Visual Evoke Potential 
(VEP). Updated standards of the International Society 
for Clinical Electrophysiology of Vision (ISCEV) 
[25,26,27,28,29,30,31] were followed to obtain all 
recordings, using a Roland Consult® equipment with the 
application software RETIscan 3.20/RETIport 32. The 
procedures were as follows: 
VEP recording was carried out by stimulating the patient 
with a Pattern reversal displayed on screen width 8.5º 
and stimuli squares spanned at a visual angle of 0.5º (30 
min). No pupil dilation was induced in the patient and the 
necessary refraction was used to fix the central point in 
the screen, indicated by a red cross. The active electrode 
was placed two centimetres above the inion on the 
medium line (OZ) according to the international system 
10-20. After that, a reference electrode was placed on 
the forehead (Fz) and a third electrode at Cz level as 
earth electrode. The impedance of the electrodes was 
kept under 5kΩ (with less than 20% difference between 
electrodes) using abrasive paste Everi® from Spes 
Médica (Gennova, Italy) to clean the skin, applied with 
sterile gauze pads. The surface electrodes were filled with 
conductive paste Ten20®Conductive and were fixed on 
the skin with Micropore™ Hipoalergenic tape from 3M 
(Minnesota, USA). Both eyes were stimulated separately 
and a maximum of 100 responses were averaged for each 
eye until a stable wave shape was reached. The study was 
repeated in a retest to ensure a reproducible response, 
and changes in the latency and amplitude of P100 wave 
(P100 latency and P100-N135 amplitude) were assessed.
PERG was carried out by stimulating the patient with 
a Pattern reversal, keeping the width of the screen at a 
visual angle of 8.5º and the size of the stimulus squares at 
1º (60 min). The active HK-Loop electrodes were placed 
inside the conjunctival sac to prevent vision interferences. 
The surface reference electrodes were located on the 
external edge of each eye, and the ground electrode 
was placed on the forehead. Impedance in electrodes 
was kept at the same values as in VEP recording. Both 
eyes were simultaneously stimulated and a maximum of 
200 responses averaged for each eye until a stable wave 
shape was reached. Changes in latency and amplitude of 
P50 wave (P50 latency and P50-N95 amplitude) were 
assessed.
mfERG was carried out with a CRT monitor with a 
central fixation point marked with a X across the entire 
screen. The stimulus array consisted of 103 hexagons 
which change from black to white in a pseudo-random 
way. The patient was placed with a fixation angle on the 
screen of 30 min with the head resting on an adjustable 
chin cup, and a minimum of 8 exploration cycles (at least 
one minute each) and a maximum of 12 (until responses 
that could be assessed were obtained) were displayed. 
The same electrodes as in the PERG were used. Pupils 
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had been dilated with pupil diameter of at least 7 mm. 
Refraction was corrected with lenses enabling the 
patients to fixate the screen properly. 
The changes observed in the mfERG evaluated the central 
30º of the retina following a standard distribution in rings 
and quadrants. Rings were numbered 1 to 6, number 1 
being the central, and number 6 the most peripheral. Ring 
1 corresponded to an area of 0 to 3 deg²; ring 2 to 13 deg², 
ring 3 to 18 deg², ring 4 to 25 deg², ring 5 to 32 deg² and 
ring 6 to 40 deg². Quadrant 1 consisted of the average 
response of the mfERG from the upper right quadrant of 
retinal view; quadrant 2 from the lower right; quadrant 3 
from the lower left; and quadrant 4 from the upper left. 
Each of these response averages had an area of 32 deg².
Ganzfeld ERG was carried out with maximal pupil 
dilation by application of drops of Tropicamida (Alcon 
Cusí, El Masnou, Barcelona) and Fenilefrina (Alcon Cusí, 
El Masnou, Barcelona), until pupil diameter reached 7 
mm in size. Electrodes were placed as in PERG. 
Stimulus was presented using a Ganzfeld dome (Q450HF 
RolandConsult®) as recommends ISCEV to allow the 
control of stimuli diffusion as well as the background light. 
A high-pass 1Hz filter and low-pass 300Hz were used.
The procedure was as follows:
1. Scotopic conditions: recorded after at least 25 minutes 
of dark adaptation.
1.1. Rod response: Stimulated by a low intensity (0.01 
cd_s_m-2) and frequency (0,2 Hz) flash. 
1.2. Mixed response: Stimulated by a high intensity (3.0 
cd_s_m-2) and low frequency (0,3 Hz) flash. This ERG 
response is a mixed rod-cone response, being therefore 
the maximum amplitude recording. 
1.3. Oscillatory potentials: we used the same conditions 
as in the mixed response but using a frequency filter 
(high-pass 100Hz filter and low-pass 500Hz) which 
magnify the amplitude wavelets on the ascending limb 
of the b-wave. High intensity (3.0 cd_s_m-2) and low 
frequency (0,1 Hz) were used.
2. Photopic conditions: recorded after at least 10 minutes 
of light adaptation by steady light backgrounds (30 cd_m-
2). Under this condition rod response is suppressed, and 
only cone response is recorded.
2.2. Cone response: Stimulated by a high intensity (3.0 
cd_s_m-2) and low frequency (0,2 Hz) flash.
2.3. Flicker response. Stimulated by a high intensity (3.0 
cd_s_m-2) and high frequency (30 Hz) flash, to study the 
macular cone response.
b-wave amplitude was measured in rods, cones and mixed 
response. The amplitude of the oscillatory potentials was 
taken as the sum of the amplitudes of the four peaks. 
Flicker response was evaluated by measuring the second-
harmonic amplitude.
3. Results
All the patients were men with an average age of 
42,6 being the younger 37 and the older 54 years old. 
Visual acuity was normal in all cases as well as fundus 
photography and visual field test.
The OCT showed no significant changes in the retinal 
nerve fiber layer thickness average although a mild 
decrease was observed in three patients (Figure 1). 
Measurable alterations in the different retinal layers were 
not observed either.
No significant changes were observed in VEP or PERG.
Figure 1: OCT study:  Recording obtained from one of the patients showing mild alterations in the nasal quadrant, but without changes in the average 
of the retinal nerve fiber layer thickness.
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Regarding electrophysiological tests, five patients 
showed abnormal responses (Table 1). In these five 
patients several alterations were observed in mfERG. 
Thus, alterations in the upper half field (mainly in the 
periphery) were observed in four patients (Figure 2). In 
one of them the alteration was observed in the temporal 
half field of both eyes while in another patient the 
impairment was observed in the nasal half field of both 
eyes. All the impairments were observed in the periphery, 
central areas were not affected.
In Ganzfeld ERG a mild decrease of b wave amplitude 
was registered in four patients. All of them showed an 
impairment of the mixed response although only in one of 
them was monocular. The ratio b/a was inverted in one of 
the patients (Figure 3). Two patients showed a decrease 
in rod response in both eyes and in cones response in one 
eye. Only one patient showed all ERG responses altered.
4. Discussion
Standard ophthalmic tests did not show signs of an 
ocular disease in alcoholic patients, since visual acuity 
was normal in all cases as well as fundus photography 
and visual field test. Although the OCT showed mild 
alterations in the retinal nerve fiber layer thickness in 
some patients, these findings are not enough to confirm 
any ocular disease.
However, when electrical function was studied, different 
alterations were observed in almost all patients, thus 
indicating that alcohol toxicity also affects the retina. It 
has been documented that electrophysiological tests are 
very sensitive to detect early stages of retinal degenerative 
disorders [32,33], therefore the alterations observed in 
these alcoholic patients could be the first step to assess 
the existence of an alcoholic retinopathy. 
Figure 2: MF-ERG response: peripheral response shows a mild decrease in the upper half field.
Patient Eye G-ERG G-ERG b/a P-VEP AMP P-VEP LAT P-ERG AMP P-ERG LAT MF-ERG
1
Right N N N N N N N
Left N N N N N N N
2
Right N N N N N N Pat
Left N N N N N N Pat
3
Right Pat N N N N N Pat
Left N N N N N N Pat
4
Right Pat Pat N Pat N N Pat
Left Pat Pat N Pat N N Pat
5
Right Pat N N N N N Pat
Left Pat N N N N N Pat
6
Right Pat N N N Pat N Pat
Left Pat N N N N N Pat
Table 1: Relevant parameters of ERG from study subjects. ERG results: N: Normal; Pat: pathological; G-ERG: Ganzfeld-ERG; G-ERG b/a: b/a ratio; 
P-VEP: Pattern VEP; P-ERG: Pattern-ERG; AMP: amplitude; LAT: latency; MF-ERG: Multifocal-ERG.
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No changes in VEP were observed since visual acuity 
was normal in all cases, and VEP is only affected when 
the central 10° of the retina are altered. However, this 
technique is necessary when visual acuity is altered 
since alcoholic neuropathy can affect the optic nerve 
[5]. Moreover, concomitant consumption of alcohol and 
tobacco can induce optic neuritis [34].
PERG neither revealed pathological findings. This is not 
surprising because no signs of central retinal injury were 
observed, and PERG is sensitive to macular damage. 
Moreover, PERG is also impaired when ganglion cells 
are damaged and there are no signs that suggest optic 
neuropathy.
mfERG, which evaluates the central 30º of the retina 
following a distribution in rings and quadrants, showed a 
decrease of the response in the upper half fields, mainly 
in the periphery. These alterations were mild and showed 
an irregular pattern. No impairments were observed 
in the central region of the retina. Such alteration of 
responses in peripheral retina is also observed in other 
toxic retinopathies as produced by DDI (dideoxyinosine) 
[35] or vigabratrin, which produces affectation in both 
inner and external retina [36,37].
ERG measures the stimulation of the entire retina. 
We report an alteration of the mixed response, thus 
confirming the existence of a retinal injury in alcoholic 
patients. There are no results indicating exclusive 
photoreceptor cellular damage, since cones and rods 
responses are normal. One patient showed an inverted 
b/a ratio which is a common finding in diseases such 
as X-linked juvenile retinoschisis, congenital stationary 
night blindness, central retinal artery occlusion, birdshot 
chorioretinopathy or melanoma-associated retinopathy 
[38], and reflects inner retinal dysfunction. Fundus 
examination is rarely diagnosed in these disorders and 
therefore, careful electrophysiological assessment of 
retinal function is needed for accurate diagnosis [39]. It 
is remarkable that only one patient showed this kind of 
impairment, being the most frequent event in this study 
the decrease of b wave amplitude, but without b/a wave 
ratio inversion.
Although ‘alcoholic retinopathy’ has not yet been 
described as a disease and no defining diagnostic criteria 
exist at the moment, our research group has previously 
reported injury induced by ethanol consumption 
showing biochemical, histological and functional 
alterations in rat retina [8,23]. In the present study 
carried out in alcoholic patients, standard ophthalmic 
tests did not show signs of ocular disease. However, 
when electrical function was studied, different 
impairments were observed in almost all patients. The 
alterations reported in mfERG and ERG recordings 
could reflect inner retina injury, thus supporting the 
possible existence of a real ‘alcoholic retinopathy’. 
Unfortunately, the number of patients is insufficient to 
conclude that alcoholic retinopathy exists in humans. 
Only six patients in Alcoholism Treatment Unit were 
eligible to enter the study since alcoholic patients 
usually have systemic diseases associated with their 
disease that can affect the responses in the visual 
pathway. In addition, it must be considered that many 
patients have nutritional and deficiency alterations that 
can also cause damage in the retina. Further studies with 
a bigger number of subjects are necessary to confirm the 
results herein and assess the impact of other factors such 
as tobacco or nutritional status.
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